Skip to content

Elizabeth Iorns

  • Ph.D.
  • Co-founder and CEO
  • Science Exchange
  • 14PublicationsNumber of items in Elizabeth's My Publications folder on Mendeley.
  • 16Followers

Research interests

My research focuses on identifying and characterizing genes that regulate breast cancer development and progression using innovative techniques.

About

Dr. Elizabeth Iorns is co-founder and chief executive officer of Science Exchange, the online marketplace for science experiments. The mission of Science Exchange is to improve the efficiency of scientific research by making it easy for researchers to access resources and experimental expertise at any research institution. She has a Ph.D. in Cancer Biology from the Institute of Cancer Research in London, and a Post Doctorate in Cancer Biology from the University of Miami’s Miller School of Medicine. She has received a range of honors, including the 2012 Kauffman Foundation Emerging Entrepreneur Award, the Expedition Inspiration Fund for Breast Cancer Research Young Investigator Award and is a graduate of the Y Combinator Summer 2011 program. Based on her own experiences as a young investigator seeking core facility capabilities and collaborations, Dr. Iorns co-founded Science Exchange. In 2012, after recognizing the need to create a positive incentive system that rewards independent validation of results, Dr. Iorns created the Reproducibility Initiative.

Groups

Followers (16)

Explore network

Following (5)

Publications (5)

  • Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.

    • Sartelet H
    • Durrieu L
    • Fontaine F
    • et al.
    N/AReaders
    N/ACitations
  • Human Melanoma Metastasis in NSG Mice Correlates with Clinical Outcome in Patients

    • Quintana E
    • Piskounova E
    • Shackleton M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin α in RhoA stabilization.

    • Wong J
    • Iorns E
    • Rheault M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models.

    • Iorns E
    • Clarke J
    • Ward T
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor.

    • Iorns E
    • Ward T
    • Dean S
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Co-founder and CEO

Science Exchange

May 2011 - Present

Assistant Professor

University of Miami Miller School of Medicine

June 2010 - Present

Scientific Officer

Breakthrough Breast Cancer Research Center, Institute of Cancer Research

Graduate student

Breakthrough Breast Cancer Research Center, Institute of Cancer Research

Honors Student

The University of Auckland

Postdoctoral Associate

University of Miami Miller School of Medicine

Education

Y Combinator

May 2011 - August 2011(3 months)

Ph.D. in Cancer Biology

Breakthrough Breast Cancer Research Center, Institute of Cancer Research

B.Sc (Hons) in Biomedical Science

The University of Auckland